Alpha Teknova, Inc. (TKNO) Stock

Alpha Teknova, Inc. specializes in supplying essential reagents critical to the global life sciences sector. With a robust presence in both domestic and international markets, Alpha Teknova's products play a pivotal role in facilitating the discovery, development, and production of biopharmaceuticals. These include crucial components for drug therapies, innovative vaccines, and molecular diagnostics, supporting advancements in medical research and healthcare solutions worldwide.

Founded in 1996 and headquartered in Hollister, California, Alpha Teknova, Inc. has established itself as a key player in the industry. The company's comprehensive product portfolio encompasses pre-poured media plates tailored for optimal cell growth and cloning, liquid cell culture media essential for cellular expansion, and a wide range of molecular biology reagents essential for sample manipulation, resuspension, and purification processes.

Alpha Teknova serves a diverse clientele across various sectors within the life sciences industry. Its customer base includes pharmaceutical and biotechnology firms, contract development and manufacturing organizations (CDMOs), in vitro diagnostic franchises, as well as academic and governmental research institutions. By consistently delivering high-quality reagents and fostering innovation, Alpha Teknova continues to uphold its commitment to advancing scientific progress and enabling breakthroughs in biopharmaceutical research and development.